Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0U0XL
|
||||
Former ID |
DIB009051
|
||||
Drug Name |
NN-7415
|
||||
Synonyms |
NNC-0172-0000-2021
|
||||
Indication | Factor IX deficiency [ICD10:D67] | Phase 1 | [523229] | ||
Company |
Novo Nordisk A/S
|
||||
Target and Pathway | |||||
Target(s) | Tissue factor pathway inhibitor | Target Info | Modulator | ||
KEGG Pathway | Complement and coagulation cascades | ||||
NetPath Pathway | IL4 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
PANTHER Pathway | Blood coagulation | ||||
Pathway Interaction Database | Syndecan-4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.